MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on April 13
MedAvail Holdings, Inc. (Nasdaq: MDVL) is set to announce its financial results for the fourth quarter and full year ended December 31, 2022, on April 13, 2023, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
MedAvail Holdings, Inc. (Nasdaq: MDVL) is set to announce its financial results for the fourth quarter and full year ended December 31, 2022, on April 13, 2023, after market close. The management will host a conference call and webcast at 4:30 PM EDT to discuss these results. Investors can join the call via a dedicated dial-in number or by accessing the live audio webcast through MedAvail's investor relations website. MedAvail specializes in pharmacy technology, providing in-clinic pharmacy services through its MedCenter robotic dispensing platform, aiming to enhance drug adherence and health outcomes for patients.
Positive
- Upcoming financial results announcement may reflect operational improvements.
- Management engagement through a conference call may boost investor confidence.
Negative
- None.
Details
News Market Reaction – MDVL
The recorded move for MDVL in the trading session of this news was +29.41%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Management to host investor conference call and webcast at 4:30pm EDT on that day
PHOENIX, April 12, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today announced that the Company will announce financial results for the fourth quarter and full-year ended December 31, 2022, on Thursday, April 13th, after the close of the financial markets. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Call and webcast details:
Thursday, April 13th, 2023 @ 4:30pm ET
Investor dial-in: 1-877-704-4453 (domestic) or 1-201-389-0920 (international)
Conference ID: 13737951
To access the Call me™ feature, which avoids having to wait for an operator, click here.
The live audio webcast can be accessed by registering online on the “Investor Relations” section of MedAvail’s website at: https://investors.medavail.com. The webcast will be archived and available for replay after the event.
About MedAvail
MedAvail Holdings, Inc. (NASDAQ: MDVL) is a pharmacy technology company, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.
Contacts:
Investor Relations
Steven Halper/Caroline Paul
Managing Directors, LifeSci Advisors
ir@medavail.com
SOURCE MedAvail Holdings, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.